Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses

Journal of Immunology

Volumn 164, Issue 7, 2000, Pages 3755-3763

  Vassallo, Robert ^a   Standing, Joseph E ^a   Limper, Andrew H ^a,b  

^a Division of Pulmonary   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BETA GLUCANASE; BETA GLUCAN; DEXAMETHASONE; GLUCAN; LAMINARAN; MACROPHAGE INFLAMMATORY PROTEIN 2; MANNAN; MANNOSE RECEPTOR; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CELL INFILTRATION; CELL WALL; CONTROLLED STUDY; CYTOKINE RELEASE; INFLAMMATION; LOWER RESPIRATORY TRACT; LUNG ALVEOLUS MACROPHAGE; NEUTROPHIL; NONHUMAN; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; RAT;

EID: 0034176743     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.7.3755     Document Type: Article

References (55)

1. Limper, A. H., K. P. Offord, T. F. Smith, and W. J. d. Martin. 1989. Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am. Rev. Respir. Dis. 140:1204.
2. Yale, S. H., and A. H. Limper. 1996. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin. Proc. 71:5.
3. Mason, G. R., C. H. Hashimoto, P. S. Dickman, L. F. Foutty, and C. J. Cobb. 1989. Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. Am. Rev. Respir. Dis. 139:1336.
4. Wright, T. W., C. J. Johnston, A. G. Harmsen, and J. N. Finkelstein. 1999. Chemokine gene expression during Pneumocystis carinii-driven pulmonary inflammation. Infect. Immun. 67:3452.
5. Smith, R. L., W. M. el-Sadr, and M. L. Lewis. 1988. Correlation of bronchoalveolar lavage cell populations with clinical severity of Pneumocystis carinii pneumonia. Chest 93:60.
6. Edman, J. C., J. A. Kovacs, H. Masur, D. V. Santi, H. J. Elwood, and M. L. Sogin. 1988. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 334:519.
7. Matsumoto, Y., S. Matsuda, and T. Tegoshi. 1989. Yeast glucan in the cyst wall of Pneumocystis carinii. J. Protozool. 36:21S.
8. Shematek, E. M., J. A. Braatz, and E. Cabib. 1980. Biosynthesis of the yeast cell wall. I. Preparation and properties of β-(1 leads to 3)glucan synthetase. J. Biol. Chem. 255:888.
9. Duffus, J. H., C. Levi, and D. J. Manners. 1982. Yeast cell-wall glucans. Adv. Microb. Physiol. 23:151.
10. Abel, G., and J. K. Czop. 1992. Stimulation of human monocyte β-glucan receptors by glucan particles induces production of TNF-α and IL-1β. Int. J. Immunopnarmacol. 14:1363.
11. Castro, M., T. I. Morgenthaler, O. A. Hoffman, J. E. Standing, M. S. Rohrbach, and A. H. Limper. 1993. Pneumocystis carinii induces the release of arachidonic acid and its metabolites from alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 9:73.
12. Olson, E. J., J. E. Standing, N. Griego-Harper, O. A. Hoffman, and A. H. Limper. 1996. Fungal β-glucan interacts with vitronectin and stimulates tumor necrosis factor α release from macrophages. Infect. Immun. 64:3548.
13. Rudmann, D. G., A. M. Preston, M. W. Moore, and J. M. Beck. 1998. Susceptibility to Pneumocystis carinii in mice is dependent on simultaneous deletion of IFN-γ and type 1 and 2 TNF receptor genes. J. Immunol. 161:360.
14. Chen, W., E. A. Havell, and A. G. Harmsen. 1992. Importance of endogenous tumor necrosis factor α and γ interferon in host resistance against Pneumocystis carinii infection. Infect. Immun. 60:1279.
15. Kolls, J. K., D. Lei, C. Vazquez, G. Odom, W. R. Summer, S. Nelson, and J. Shellito. 1997. Exacerbation of murine Pneumocystis carinii infection by adenoviral-mediated gene transfer of a TNF inhibitor. Am. J. Respir. Cell Mol. Biol. 16:112.
16. Yu, M. L., and A. H. Limper. 1997. Pneumocystis carinii induces ICAM-1 expression in lung epithelial cells through a TNF-α-mediated mechanism. Am. J. Physiol. 273:L1103.
17. Ward, P. A. 1998. Thematic review series I: lung biology of chemokines and cytokines: introduction. Proc. Assoc. Am. Physicians 110:287.
18. Bozic, C. R., N. P. Gerard, C. von Uexkull-Guldenband, L. F. Kolakowski, Jr., M. J. Conklyn, R. Breslow, H. J. Showell, and C. Gerard. 1994. The murine interleukin 8 type B receptor homologue and its ligands: expression and biological characterization. J. Biol. Chem. 269:29355.
19. Bozzette, S. A., F. R. Sattler, J. Chiu, A. W. Wu, D. Gluckstein, C. Kemper, A. Bartok, J. Niosi, I. Abramson, J. Coffman, et al. 1990. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: California Collaborative Treatment Group. N. Engl. J. Med. 323:1451.
20. The National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia. 1990. Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome. N. Engl. J. Med. 323: 1500.
21. Refsum, S. E., M. I. Halliday, G. Campbell, M. McCaigue, B. J. Rowlands, and V. E. Boston. 1996. Modulation of TNF α and IL-6 in a peritonitis model using pentoxifylline. J. Pediatr. Surg. 31:928.
22. Sampaio, E. P., M. O. Moraes, J. A. Nery, A. R. Santos, H. C. Matos, and E. N. Sarno. 1998. Pentoxifylline decreases in vivo and in vitro tumor necrosis factor-α (TNF-α) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL). Clin. Exp. Immunol. 111:300.
23. van Furth, A. M., E. M. Verhard-Seijmonsbergen, R. van Furth, and J. A. Langermans. 1997. Effect of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-α, IL-1β, IL-10 by human leukocytes. Immunology 91:193.
24. Hoffman, O. A., J. E. Standing, and A. H. Limper. 1993. Pneumocystis carinii stimulates tumor necrosis factor-α release from alveolar macrophages through a β-glucan-mediated mechanism. J. Immnunol. 150:3932.
25. Tamburrini, E., A. De Luca, G. Ventura, G. Maiuro, A. Siracusano, E. Ortona, and A. Antinori. 1990. Macrophages from healthy adults release TNF-α after exposure to Pneumocystis carinii of murine origin: preliminary study. Medicina 10:393.
26. Limper, A. H., J. S. Hoyte, and J. E. Standing. 1997. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. J. Clin. Invest. 99:2110.
27. Limper, A. H., M. Edens, R. A. Anders, and E. B. Leof. 1998. Pneumocystis carinii inhibits cyclin-dependent kinase activity in lung epithelial cells. J. Clin. Invest. 101:1148.
28. Thomas, C. F., R. A. Anders, M. P. Gustafson, E. B. Leof, and A. H. Limper. 1998. Pneumocystis carinii contains a functional cell-division-cycle Cdc2 homologue. Am. J. Respir. Cell Mol. Biol. 18:297.
29. Figueiredo, F., L. M. Alves, and C. L. Silva. 1993. Tumor necrosis factor production in vivo and in vitro in response to Paracoccidioides brasiliensis and the cell wall fractions thereof. Clin. Exp. Immunol. 93:189.
30. Silva, C. L., L. M. Alves, and F. Figueiredo. 1994. Involvement of cell wall glucans in the genesis and persistence of the inflammatory reaction caused by the fungus Paracoccidroides brasiliensis. Microbiology 140:1189.
31. Bacon, J. S., V. C. Farmer, D. Jones, and I. F. Taylor. 1969. The glucan components of the cell wall of baker's yeast (Saccharomyces cerevisiae) considered in relation to its ultrastructure. Biochem. J. 114:557.
32. Kennedy, J. F., and G. Pagliuca. 1994. In Carbohydrate Analysis. M. F. Chaplin and J. F. Kennedy, eds. Oxford University Press, Oxford, p. 44.
33. Limper, A. H., U. Specks, W. M. Brutinel, W. J. d. Martin, and M. S. Rohrbach. 1993. Interlobar variation in the recovery of bronchoalveolar lavage fluid, cell populations, and angiotensin-converting enzyme in normal volunteers. J. Lab. Clin. Med. 121:785.
34. Castro, M., N. V. Ralston, T. I. Morgenthaler, M. S. Rohrbach, and A. H. Limper. 1994. Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through α-mannan and β-glucan cell wall components. Infect. Immun. 62:3138.
35. Kramer, S. M., and M. E. Carver. 1986. Serum-free in vitro bioassay for the detection of tumor necrosis factor. J. Immunol. Methods 93:201.
36. Turtinen, L. W., and B. D. Juran. 1998. Standardization and comparison of an XTT-based TNF-α bioassay with a TNF-α ELISA. BioTechniques 24:232.
37. Neese, L. W., J. E. Standing, E. J. Olson, M. Castro, and A. H. Limper. 1994. Vitronectin, fibronectin, and gp120 antibody enhance macrophage release of TNF-α in response to Pneumocystis carinii. J. Immunol. 152:4549.
38. Czop, J. K., and J. Kay. 1991. Isolation and characterization of β-glucan receptors on human mononuclear phagocytes. J. Exp. Med. 173:1511.
39. Giaimis, J., Y. Lombard, P. Fonteneau, C. D. Muller, R. Levy, M. Makaya-Kumba, J. Lazdins, and P. Poindron. 1993. Both mannose and β-glucan receptors are involved in phagocytosis of unopsonized, heat-killed Saccharomyces cerevisiae by murine macrophages. J. Leukocyte Biol. 54:564.
40. O'Riordan, D. M., J. E. Standing, and A. H. Limner. 1995. Pneumocystis carinii glycoprotein A binds macrophage mannose receptors. Infect. Immun. 63:779.
41. Millar, A. B., R. F. Miller, N.M. Foley, A. Meager, S. J. Semple, and G. A. Rook. 1991. Production of tumor necrosis factor-α by blood and lung mononuclear phagocytes from patients with human immunodeficiency virus-related lung disease. Am. J. Respir. Cell Mol. Biol. 5:144.
42. Vilcek, J., and T. H. Lee. 1991. Tumor necrosis factor: new insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 266:7313.
43. 125I-labelled tumor necrosis factor to Pneumocystis carinii and an insoluble cell wall fraction. J. Protocol. 38:28S.
44. Pesanti, E. L. 1991. Interaction of cytokines and alveolar cells with Pneumocystis carinii in vitro. J. Infect. Dis. 163:611.
45. Hyers, T. M., S. M. Tricomi, P. A. Dettenmeier, and A. A. Fowler. 1991. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 144:268.
46. Jaattela, M. 1991. Biologic activities and mechanisms of action of tumor necrosis factor-α/cachectin. Lab. Invest. 64:724.
47. Gagnon, S., A. M. Boota, M. A. Fischl, H. Baier, O. W. Kirksey, and L. La Voie. 1990. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a double-blind, placebo-controlled trial. N. Engl. J. Med. 323:1444.
48. Kullmann, A., P. Vaillant, V. Muller, Y. Martinet, and N. Martinet. 1993. In vitro effects of pentoxifylline on smooth muscle cell migration and blood monocyte production of chemotactic activity for smooth muscle cells: potential therapeutic benefit in the adult respiratory distress syndrome. Am. J. Respir. Cell Mol. Biol. 8:83.
49. Sheridan, B. C., R. C. McIntyre, D. R. Meldrum, and D. A. Fullerton. 1997. Pentoxifylline treatment attenuates pulmonary vasomotor dysfunction in acute lung injury. J. Surg. Res. 71:150.
50. Kolls, J. K., J. M. Beck, S. Nelson, W. R. Summer, and J. Shellito. 1993. Alveolar macrophage release of tumor necrosis factor during murine Pneumocystis carinii pneumonia. Am. J. Respir. Cell Mol. Biol. 8:370.
51. Corsini, E., C. Dykstra, W. A. Craig, R. R. Tidwell, and G. J. Rosenthal. 1992. Pneumocystis carinii induction of tumor necrosis factor-α by alveolar macrophages: modulation by pentamidine isethionate. Immunol. Lett. 34:303.
52. Ezekowitz, R. A., D. J. Williams, H. Koziel, M. Y. Armstrong, A. Warner, F. F. Richards, and R. M. Rose. 1991. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 351:155.
53. Hidalgo, H. A., R. J. Helmke, V. F. German, and J. A. Mangos. 1991. Role of the zymolyase sensitive cell wall of Pneumocystis carinii in the oxidative burst of macrophages. J. Protozool. 38:38S.
54. Okazaki, M., Y. Adachi, N. Ohno, and T. Yadomae. 1995. Structure-activity relationship of (1→3)-β-D-glucans in the induction of cytokine production from macrophages, in vitro. Biol. Pharm. Bull. 18:1320.
55. Michalek, M., D. Melican, D. Brunke-Reese, M. Langevin, K. Lemerise, W. Galbraith, M. Patchen, and W. Mackin. 1998. Activation of rat macrophages by Betafectin PGG-glucan requires cross-linking of membrane receptors distinct from complement receptor three (CR3). J. Leukocyte Biol. 64:337.